ImageneBio, Inc.
IMA
Last
$4.24
Day
-0.5%
1y
-48.2%
5y
-87.7%
52w
-53.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1132d
EMA 21
4.70
EMA 50
5.03
EMA 200
7.24
20d high
-21.0%
5y high
-93.4%
5y range
1th
Positions held
Your positionsIMA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$4.60
Stop
$3.98
Stop distance
6.1%
Target vs last
+8.5%
Fundamentals
| Market cap | $48.45M | Enterprise value | -$85.88M | Trailing P/E | — | Forward P/E | -0.99 |
| PEG | — | Price / book | 0.34 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -82.7% | ROA | -43.1% | Debt / equity | 0.01 |
| Current ratio | 21.47 | Free cash flow | -$23.21M | Analyst recommendation | none | Mean target | $18.00 |
| 52w high | $9.10 | 52w low | $3.94 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$10.2M | -$10.6M | -$6.9M | -$24.8M | -$7.6M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$11.8M | -$12.1M | -$8.5M | -$26.6M | -$7.4M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $0.8M | $3.5M | $8.0M |
| Op margin | -6056.4% | -1057.1% | -275.4% |
| Net income | -$45.3M | -$36.6M | -$21.1M |
| Gross margin | — | — | — |
| Gross profit | — | — | — |
| Operating income | -$48.5M | -$37.0M | -$21.9M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-02 · ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-08 · ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
2026-08-17 · ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-08-05 · ImageneBio Reports Second Quarter 2026 Financial Results
Price (daily)
Full chart · RSI · MACD · patternsIMA · daily-12.2% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin